A new approach to mental health – the Health Heroes podcastThe third episode of Kantar’s Health Heroes podcast looks at the effects of increased anxiety on patients’ attitudes Share XA new approach to mental health – the Health Heroes podcasthttps://pharmaphorum.com/podcast/mental-health-covid-19-telehealth/
Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum podcastJoining the pharmaphorum podcast for episode 24 is Gitte Aabo, who last year moved to hearing aid technology Share XGitte Aabo on telemedicine and GN Hearing: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gitte-aabo-telemedicine-gn-hearing
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse LabAlderley Park’s Mereside campus is at the forefront of the UK’s COVID-19 testing plans, playing a key role Share XThe Alderley Park Discovery Podcast: COVID testing and the Lighthouse Labhttps://pharmaphorum.com/podcast/alderley-park-discovery-podcast-lighthouse-lab/
3 ways pharma marketers can draw inspiration from digitally-native brandsAs pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can Share X3 ways pharma marketers can draw inspiration from digitally-native brandshttps://pharmaphorum.com/views-and-analysis/3-ways-pharma-marketers-can-draw-inspiration-from-digitally-native-brands/
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcastAlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing Share XAlnylam, gene-silencing and biotech in 2020: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/alnylam-gene-silencing-biotech-2020/
Bayer strikes $98m deal with digital health firm One DropBayer has taken a further stake in New York-based One Drop to support its plans to become a Share XBayer strikes $98m deal with digital health firm One Drophttps://pharmaphorum.com/news/bayer-digital-health-one-drop/
NHS telemedicine ambitions approach a pivotal pointThe UK government has said it is vital to adopt telemedicine across the NHS in response to COVID-19 Share XNHS telemedicine ambitions approach a pivotal pointhttps://pharmaphorum.com/views-analysis-digital/nhs-telemedicine-ambitions-approach-a-pivotal-point/
The acceleration of pharma’s digital transformationFrom this summer’s vantage point 2019 seems like it was at least a decade ago, such is the Share XThe acceleration of pharma’s digital transformationhttps://pharmaphorum.com/digital/the-acceleration-of-pharmas-digital-transformation/
Novartis, company culture and COVID-19: the pharmaphorum podcastNovartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face Share XNovartis, company culture and COVID-19: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-company-culture-covid-19/
